Discontinued — last reported Q3 '24
Agilent Technologies Agilent CrossLab — CapEx remained flat by 0.0% to $4.75M in Q3 2024 compared to the prior quarter. Year-over-year, this metric declined by 13.6%, from $5.50M to $4.75M. Over 2 years (FY 2022 to FY 2024), Agilent CrossLab — CapEx shows a downward trend with a -24.1% CAGR.
Higher spending generally signals growth initiatives and capacity expansion, whereas lower spending may indicate a focus on cash preservation or a mature, low-growth phase.
The cash outflows used by the segment to acquire, upgrade, or maintain physical assets such as property, buildings, and...
Standard segment-level capital expenditure reporting found in the 'Segment Information' or 'Cash Flow' notes of annual reports.
a_segment_agilent_crosslab_capital_expenditures| FY'22 | FY'23 | FY'24 | |
|---|---|---|---|
| Value | $33.00M | $22.00M | $19.00M |
| YoY Change | — | -33.3% | -13.6% |